| Literature DB >> 12655365 |
Katarzyna Kania1, Sylwia Dragojew, Zofia Jóźwiak.
Abstract
We show that treating human trisomic fibroblasts with anthracyclines - aclarubicin, daunorubicin and idarubicin - leads to certain changes in these cells; namely the activation of caspase 3, morphological changes and an increase in the level of intracellular calcium. These results suggest that anthracycline drugs are also able to induce apoptosis in pathological, trisomic cells.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12655365
Source DB: PubMed Journal: Cell Mol Biol Lett ISSN: 1425-8153 Impact factor: 5.787